Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06363760
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-04-12
First Post:
2024-04-09
Brief Title:
A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301
Sponsor:
Editas Medicine Inc
Organization:
Editas Medicine Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hemoglobinopathies |
| Sickle Cell Disease |
| Transfusion-dependent Beta-Thalassemia |
Keywords:
| Name | View |
|---|---|
| Anemia Hemolytic | View |
| Sickle Cell Disease | View |
| Sickle Cell Anemia | View |
| Sickling Disorder Due to Hemoglobin S | View |
| Beta-Thalassemia | View |
| Thalassemia Major | View |
| Thalassemia Intermedia | View |
| Hemoglobinopathies | View |
| CRISPR-Cas12a | View |
| Autologous CD34 | View |
| Genetic Diseases Inborn | View |
| Hematologic Diseases | View |
| Anemia | View |
| Anemia Hemolytic Congenital | View |